<p>Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein–Barr Virus Reactivation</p>-Reference-Cited by-同舟云学术

Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein–Barr Virus Reactivation

Published:2019-12 Issue: Volume:Volume 12 Page:3893-3902
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Czyzewski Krzysztof^ORCID,Dziedzic Magdalena,Salamonowicz Malgorzata,Fraczkiewicz Jowita^ORCID,Zajac-Spychala Olga^ORCID,Zaucha-Prazmo Agnieszka,Gozdzik Jolanta,Galazka Przemyslaw^ORCID,Bartoszewicz Natalia,Demidowicz Ewa,Styczynski Jan^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High infection rates and risk‐adapted prevention strategies in contemporary pediatric allogeneic hematopoietic stem cell transplantation;Pediatric Discovery;2024-07-14

2. Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice;Cells;2023-12-21

3. Cytomegalovirus and Epstein-Barr virus infection during daratumumab treatment in patients with multiple myeloma;Leukemia & Lymphoma;2023-02-03

4. Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients;Frontiers in Pharmacology;2022-04-14

5. Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan;Frontiers in Pediatrics;2022-02-18